Based on the MINERVA NEUROSC. DL-0001 stock forecast from 0 analysts, the average analyst target price for MINERVA NEUROSC. DL-0001 is not available over the next 12 months. MINERVA NEUROSC. DL-0001’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of MINERVA NEUROSC. DL-0001 is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, MINERVA NEUROSC. DL-0001’s stock price was EUR 2.02. MINERVA NEUROSC. DL-0001’s stock price has changed by +6.32% over the past week, -3.81% over the past month and -65.14% over the last year.
No recent analyst target price found for MINERVA NEUROSC. DL-0001
No recent average analyst rating found for MINERVA NEUROSC. DL-0001
Company Overview MINERVA NEUROSC. DL-0001
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts. Read Less
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative...Read More
Frequently Asked Questions About MINERVA NEUROSC. DL-0001 (4MNA:F) Stock
Stock Target Advisor's fundamental analysis for MINERVA NEUROSC. DL-0001's stock is Bearish.
Unfortunately we do not have enough data on 4MNA:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4MNA:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4MNA:F's stock to indicate if its overvalued.
The last closing price of 4MNA:F's stock was EUR 2.02.
The most recent market capitalization for 4MNA:F is EUR 0.01B.
Unfortunately we do not have enough analyst data on 4MNA:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains MINERVA NEUROSC. DL-0001's stock.
As per our most recent records MINERVA NEUROSC. DL-0001 has 9 Employees.
MINERVA NEUROSC. DL-0001's registered address is 1500 District Avenue, Burlington, MA, United States, 01803.
You can get more information about it from MINERVA NEUROSC. DL-0001's website at https://www.minervaneurosciences.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About MINERVA NEUROSC. DL-0001 (4MNA:F) Stock
Stock Target Advisor's fundamental analysis for MINERVA NEUROSC. DL-0001's stock is Bearish.
Unfortunately we do not have enough data on 4MNA:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4MNA:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4MNA:F's stock to indicate if its overvalued.
The last closing price of 4MNA:F's stock was EUR 2.02.
The most recent market capitalization for 4MNA:F is EUR 0.01B.
Unfortunately we do not have enough analyst data on 4MNA:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains MINERVA NEUROSC. DL-0001's stock.
As per our most recent records MINERVA NEUROSC. DL-0001 has 9 Employees.
MINERVA NEUROSC. DL-0001's registered address is 1500 District Avenue, Burlington, MA, United States, 01803.
You can get more information about it from MINERVA NEUROSC. DL-0001's website at https://www.minervaneurosciences.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4MNA:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
